Many people living with focal onset seizures (FOS) fail to achieve seizure freedom, even after taking two or more ...

Individuals with epilepsy and their caregivers want improved communication and a broader base of information from their ...

Individuals with focal onset epilepsy treated with azetukalner experienced sustained monthly seizure reduction and evidence of seizure freedom up to 48 months, according to data presented at the ...

Glucagon-like peptide-1 receptor agonist therapy is associated with a reduced risk for epilepsy in adults with type 2 diabetes mellitus.

Julia Dvorak is worried her 83-year-old mother’s emergency room trips for seizures are depleting her retirement ...

A new AP-NORC poll finds that Americans are more likely to prioritize health care than they were last year. Immigration and ...

Julia Dvorak is worried her 83-year-old mother’s emergency room trips for seizures are depleting her retirement savings and ...

A recent study points to a potential link between GLP-1 drugs and its ability to reduce risk of epilepsy in people with type 2 diabetes. GLP-1 drugs (semaglutide) are those which mimic the function of ...

Psychological interventions may be effective for achieving freedom from functional seizures, according to new practice ...

The AAN’s first-ever functional seizure guideline targets stigma and unnecessary treatment, offering clearer diagnostic steps ...